Three Potential Risk Genes for Bipolar Disorder: MT1E, MT1X and CX3CR1-Journal of Psychiatry and Brain Science-CSCIED科技核心评价数据库-手机版

Three Potential Risk Genes for Bipolar Disorder: MT1E, MT1X and CX3CR1

Three Potential Risk Genes for Bipolar Disorder: MT1E, MT1X and CX3CR1

ES评分 0 浏览量：1082 下载量：0

DOI	10.20900/jpbs.20170004
刊名	Journal of Psychiatry and Brain Science JPBS
年，卷(期)	2017, 2(2)
作者	Wei.Jin,Ashley.Chorath,Cao.Shaolong*,
作者单位	1 Department of Neurology, Tongling People's Hospital, Tongling, 244000, China; 2 Radiology and Imaging Sciences, National Institutes of Health Clinical Center, Bethesda, MD, 20892, USA; 3 Department of Bioinformatics & Computational Biology, UT MD Anderson Cancer Center, Houston, TX, 77030, USA
Abstract	Background: Bipolar disorder (BP) is one of the most common mental illnesses, with the underlying mechanisms remaining unclear. The aim of this study is to investigate the novel genetic risk of BP by systematically reviewing published literature and performing a meta-analysis.Method: A comprehensive search of electronic databases was completed using Illumina BioEngine. RNA expression data from brain tissue of 198 BP cases and 160 controls were analyzed, including six BP case/control bio-sets from four recent studies. The selected top BP risk genes were analyzed by integrating an online open source BP genetic database. Pathway enrichment analysis (PEA) and network connectivity analysis (NCA) were conducted to identify potential functional association between target genes and BP.
KeyWord	Bipolar disorder, ResNet Database, Pathway enrichment analysis, Network connectivity analysis
基金项目
页码	-

参考文献
相关文献

1.Anderson IM, Haddad PM, Scott J. BP disorder. BMJ. 2012; 345: e8508.

2.Goodwin GM. BP disorder. Medicine. 2013; 40(11): 596-598.

3.Craddock N, Forty L. Genetics of affective (mood) disorders. Eur J Hum Genet. 2006; 14(6): 660-668.

4.Nöthen MM, Nieratschker V, Cichon S, Rietschel M. New findings in the genetics of major psychoses. Dialogues Clin. Neurosci. 2010; 12: 85-93.

5.Hashimoto K. Brain-derived neurotrophic factor (BDNF) and its precursor proBDNF as diagnostic biomarkers for major depressive disorder and bipolar disorder. Eur Arch Psychiatry Clin Neurosci. 2015; 265(1): 83-84.

6.Fatemi S. Cerebellum and autism. Cerebellum. 2013; 12(5): 778-779.

7.Kato T, Hayashi-Takagi A, Toyota T, Yoshikawa T, Iwamoto K. Gene expression analysis in lymphoblastoid cells as a potential biomarker of bipolar disorder. J Hum Genet. 2011; 56(11): 779-783.

8.Jang Y, Lee SH, Lee B, Jung S, Khalid A, Uchida K, Tominaga M, Jeon D, Oh U. TRPM2, a Susceptibility Gene for Bipolar Disorder, Regulates Glycogen Synthase Kinase-3 Activity in the Brain. J Neurosci. 2015; 35(34): 11811-11823.

9.Mühleisen TW, Leber M, Schulze TG, Strohmaier J, Degenhardt F, Treutlein J, et al. Genome-wide association study reveals two new risk loci for bipolar disorder. Nat Commun. 2014; 5: 3339.

10.Ryan MM, Lockstone HE, Huffaker SJ, Wayland MT, Webster MJ, Bahn S. Gene expression analysis of BP disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes. Mol Psychiatry. 2006;11(10): 965-978.

11.Iwamoto K, Bundo M, Kato T. Altered expression of mitochondria-related genes in postmortem brains of patients with BP disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet. 2005; 14(2): 241-253.

12.Iwamoto K, Kakiuchi C, Bundo M, Ikeda K, Kato T. Molecular characterization of BP disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol Psychiatry. 2004; 9(4): 406-416.View Article<

13.Chen C, Cheng L, Grennan K, Pibiri F, Zhang C, Badner JA，Members of the Bipolar Disorder Genome Study (BiGS) Consortium, Gershon ES, Liu C. Two gene co-expression modules differentiate psychotics and controls. Mol Psychiatry. 2013; 18(12): 1308-1314.

14.Nikitin A, Egorov S, Daraselia N, Mazo I. Pathway studio--the analysis and navigation of molecular networks. Bioinformatics. 2003; 19(16): 2155-2157.

15.Yamamoto T, Kudo M, Peng WX, Naito Z. Analysis of protein expression regulated by lumican in PANC‑1 cells using shotgun proteomics. Oncol Rep. 2013; 30(4): 1609-1621.

16.Samochowiec A, Grzywacz A, Kaczmarek L, Bienkowski P, Samochowiec J, Mierzejewski P, Preuss UW, Grochans E, Ciechanowicz A. Functional polymorphism of matrix metalloproteinase-9 (MMP-9) gene in alcohol dependence: family and case control study. Brain Res. 2010; 1327: 103-106.

17.Wiese L, Kurtzhals JA, Penkowa M. Neuronal apoptosis, metallothionein expression and proinflammatory responses during cerebral malaria in mice. Exp Neurol. 2006; 200(1): 216-226.

18.Doganavsargil-Baysal O, Cinemre B, Aksoy UM, Akbas H, Metin O, Fettahoglu C, Gokmen Z, Davran F. Levels of TNF-α, soluble TNF receptors (sTNFR1, sTNFR2), and cognition in BP disorder. Hum Psychopharmacol. 2013; 28(2): 160-167.

19.Lee S, Varvel NH, Konerth ME, Xu G, Cardona AE, Ransohoff RM, Lamb BT. CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models. Am J Pathol. 2010; 177(5): 2549-2562.

引用本文

Wei.Jin,Ashley.Chorath,Cao.Shaolong*. Three Potential Risk Genes for Bipolar Disorder: MT1E, MT1X and CX3CR1, Journal of Psychiatry and Brain Science. 2017; 2; (2). https://doi.org/10.20900/jpbs.20170004.

文献评论

相关学者

相关机构